Latest weekly update supports previewing videos in the image carousel, adds a Copy Final Response command to the chat context ...
Fast Track Designation highlights potential of CTIM-76 to address unmet need for patients with PROC CTIM-76 Phase 1a trial ongoing, with interim data expected in June 2026 Javascript is required for ...
MiNK Therapeutics, Inc. (NASDAQ: INKT), a clinical-stage biopharmaceutical company pioneering allogeneic invariant natural killer T (allo-iNKT) cell therapies to restore immune balance ...
The CIO has always been at the front line of technology innovation within the enterprise, though their scope was once more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results